158 related articles for article (PubMed ID: 28900718)
21. Investigating unilateral pleural effusions: the role of cytology.
Arnold DT; De Fonseka D; Perry S; Morley A; Harvey JE; Medford A; Brett M; Maskell NA
Eur Respir J; 2018 Nov; 52(5):. PubMed ID: 30262573
[TBL] [Abstract][Full Text] [Related]
22. Etiology of Malignant Pleural Effusion and Utilization of Diagnostic and Therapeutic Procedures: A Nationwide Analysis.
Chatterjee K; Goyal A; Kakkera K; Meena N
J Bronchology Interv Pulmonol; 2017 Jan; 24(1):e10-e12. PubMed ID: 27984393
[No Abstract] [Full Text] [Related]
23. Hyperthermic intrathoracic chemotherapy for the treatment of malignant pleural effusion caused by breast and ovarian cancer: A systematic literature review and pooled analysis.
Karampinis I; Dionysopoulou A; Galata C; Almstedt K; Grilli M; Hasenburg A; Roessner ED
Thorac Cancer; 2022 Apr; 13(7):883-888. PubMed ID: 35194945
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic and prognostic values of endothelial-cell-specific molecule-1 with malignant pleural effusions in patients with non-small cell lung cancer.
Lu GJ; Shao CJ; Zhang Y; Wei YY; Xie WP; Kong H
Oncotarget; 2017 Jul; 8(30):49217-49223. PubMed ID: 28514746
[TBL] [Abstract][Full Text] [Related]
25. Prognostic impact of a new score using neutrophil-to-lymphocyte ratios in the serum and malignant pleural effusion in lung cancer patients.
Lee YS; Nam HS; Lim JH; Kim JS; Moon Y; Cho JH; Ryu JS; Kwak SM; Lee HL
BMC Cancer; 2017 Aug; 17(1):557. PubMed ID: 28830378
[TBL] [Abstract][Full Text] [Related]
26. The prognosis after contraindicated surgery of NSCLC patients with malignant pleural effusion (M1a) may be better than expected.
Ren Y; Dai C; Shen J; Liu Y; Xie D; Zheng H; He J; Liang W; Jiang G; Fei K; Yang P; He J; Chen C
Oncotarget; 2016 May; 7(18):26856-65. PubMed ID: 27057627
[TBL] [Abstract][Full Text] [Related]
27. Bedside talc pleurodesis for malignant pleural effusion: factors affecting success.
Aydogmus U; Ozdemir S; Cansever L; Sonmezoglu Y; Kocaturk CI; Bedirhan MA
Ann Surg Oncol; 2009 Mar; 16(3):745-50. PubMed ID: 19116753
[TBL] [Abstract][Full Text] [Related]
28. Clinical course of asymptomatic malignant pleural effusion in non-small cell lung cancer patients: A multicenter retrospective study.
Roh J; Ahn HY; Kim I; Son JH; Seol HY; Kim MH; Lee MK; Eom JS
Medicine (Baltimore); 2021 May; 100(19):e25748. PubMed ID: 34106603
[TBL] [Abstract][Full Text] [Related]
29. Diagnosis and management of malignant pleural effusions.
Heffner JE
Respirology; 2008 Jan; 13(1):5-20. PubMed ID: 18197908
[TBL] [Abstract][Full Text] [Related]
30. Survival in Patients With Malignant Pleural Effusions Who Developed Pleural Infection: A Retrospective Case Review From Six UK Centers.
Bibby AC; Clive AO; Slade GC; Morley AJ; Fallon J; Psallidas I; Pepperell JCT; Slade MG; Stanton AE; Rahman NM; Maskell NA
Chest; 2015 Jul; 148(1):235-241. PubMed ID: 25429399
[TBL] [Abstract][Full Text] [Related]
31. Useful Application of Immunostaining to Malignant Pleural Effusion among Lao People in Vientiane Capital, Lao PDR.
Vilayvong S; Hando K; Sekine M; Luangxay T; Arounlangsy P; Xaysomphet P; Xayaphet P; Thavisouk H; Soejima Y; Kitagawa M; Sawabe M
Asian Pac J Cancer Prev; 2019 Jan; 20(1):243-248. PubMed ID: 30678439
[TBL] [Abstract][Full Text] [Related]
32. Predictors of mortality within three months in the patients with malignant pleural effusion.
Ozyurtkan MO; Balci AE; Cakmak M
Eur J Intern Med; 2010 Feb; 21(1):30-4. PubMed ID: 20122610
[TBL] [Abstract][Full Text] [Related]
33. Decreased glucose concentration in malignant pleural effusions.
Berger HW; Maher G
Am Rev Respir Dis; 1971 Mar; 103(3):427-9. PubMed ID: 5152727
[No Abstract] [Full Text] [Related]
34. Pleural fluid microbiota as a biomarker for malignancy and prognosis.
Kwok B; Wu BG; Kocak IF; Sulaiman I; Schluger R; Li Y; Anwer R; Goparaju C; Ryan DJ; Sagatelian M; Dreier MS; Murthy V; Rafeq S; Michaud GC; Sterman DH; Bessich JL; Pass HI; Segal LN; Tsay JJ
Sci Rep; 2023 Feb; 13(1):2229. PubMed ID: 36755121
[TBL] [Abstract][Full Text] [Related]
35. Vascular endothelial growth factor and soluble intercellular adhesion molecule-1 in lung adenocarcinoma with malignant pleural effusion: correlations with patient survival and pleural effusion control.
Qian Q; Zhan P; Sun WK; Zhang Y; Song Y; Yu LK
Neoplasma; 2012; 59(4):433-9. PubMed ID: 22489699
[TBL] [Abstract][Full Text] [Related]
36. Pleural Effusion in Multiple Myeloma.
Wang Z; Xia G; Lan L; Liu F; Wang Y; Liu B; Ding Y; Dai L; Zhang Y
Intern Med; 2016; 55(4):339-45. PubMed ID: 26875957
[TBL] [Abstract][Full Text] [Related]
37. Pleural fluid mesothelin for the differential diagnosis of exudative pleural effusions.
Alemán C; Manuel Porcel J; Ma Segura R; Alegre J; Esquerda A; Ruiz E; Bielsa S; de Sevilla TF
Med Clin (Barc); 2009 Oct; 133(12):449-53. PubMed ID: 19783262
[TBL] [Abstract][Full Text] [Related]
38. Outcome and characteristics of patients with malignant pleural effusion from differentiated thyroid carcinoma.
Tomoda C; Ogimi Y; Saito F; Masaki C; Akaishi J; Matsuzu K; Suzuki A; Uruno T; Ohkuwa K; Shibuya H; Kitagawa W; Nagahama M; Sugino K; Ito K
Endocr J; 2016; 63(3):257-61. PubMed ID: 26655349
[TBL] [Abstract][Full Text] [Related]
39. Clinical course of non-small cell lung cancer patients with dry pleural dissemination: Retrospective observational study.
Kim W; Park IK; Park S; Kang CH; Kim YT
Medicine (Baltimore); 2020 Mar; 99(11):e19533. PubMed ID: 32176106
[TBL] [Abstract][Full Text] [Related]
40. Prognostic factors in patients with malignant pleural effusion: Is it possible to predict mortality in patients with good performance status?
Abrao FC; Peixoto RD; de Abreu IR; Janini MC; Viana GG; de Oliveira MC; Younes RN
J Surg Oncol; 2016 Apr; 113(5):570-4. PubMed ID: 26751412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]